Orpheris enrols first patients in phase 2 clinical study evaluating OP-101 for severe Covid-19

This article was originally published here

The study will be conducted by investigators at leading U.S. academic medical centers, including Johns Hopkins Hospital, Emory University, Loma Linda University Health and The University of Texas

The post Orpheris enrols first patients in phase 2 clinical study evaluating OP-101 for severe Covid-19 appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply